AGAPE ATP CORPORATION Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
AGAPE ATP CORPORATION (ATPC) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $153.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-14
- AGAPE ATP CORPORATION net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $153.00K.
- AGAPE ATP CORPORATION net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$327.62K.
- AGAPE ATP CORPORATION net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$376.07K.
- AGAPE ATP CORPORATION net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$595.37K.
- AGAPE ATP CORPORATION net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$2.31M.
- AGAPE ATP CORPORATION net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$2.49M.
- AGAPE ATP CORPORATION net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$2.11M.
- AGAPE ATP CORPORATION net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$1.67M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $153.00K 10-Q · filed 2026-08-14 | -$174.62K 10-Q · filed 2026-08-14 | -$550.69K derived: sum of 3 quarters · filed 2026-08-14 | -$1.15M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$327.62K 10-Q · filed 2026-05-15 | -$703.69K derived: sum of 2 quarters · filed 2026-05-15 | -$1.30M derived: sum of 3 quarters · filed 2026-05-15 | -$1.92M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$376.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$971.44K derived: sum of 2 quarters · filed 2026-04-13 | -$1.59M derived: sum of 3 quarters · filed 2026-08-14 | -$2.31M 10-K · filed 2026-04-13 | ||
| 2025-09-30 | -$595.37K 10-Q · filed 2025-11-13 | -$1.21M derived: sum of 2 quarters · filed 2026-08-14 | -$1.93M 10-Q · filed 2025-11-13 | -$2.74M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | -$617.08K 10-Q · filed 2026-08-14 | -$623.25K 10-Q · filed 2025-08-13 | -$1.32M 10-Q · filed 2026-08-14 | -$1.34M 10-Q · filed 2025-08-13 | -$2.14M derived: sum of 3 quarters · filed 2026-08-14 | -$2.67M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$698.95K 10-Q · filed 2026-05-15 | -$712.92K 10-Q · filed 2025-05-15 | -$1.53M derived: sum of 2 quarters · filed 2026-05-15 | -$2.05M derived: sum of 3 quarters · filed 2026-05-15 | -$2.48M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$826.60K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$1.35M derived: sum of 2 quarters · filed 2026-04-13 | -$1.78M derived: sum of 3 quarters · filed 2026-04-13 | -$2.49M 10-K · filed 2026-04-13 | ||
| 2024-09-30 | -$524.04K 10-Q · filed 2025-11-13 | -$956.35K derived: sum of 2 quarters · filed 2025-11-13 | -$1.66M 10-Q · filed 2025-11-13 | -$2.63M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$432.31K 10-Q · filed 2025-11-13 | -$1.14M 10-Q · filed 2025-08-13 | -$2.11M derived: sum of 3 quarters · filed 2025-11-13 | -$2.43M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-03-31 | -$703.09K 10-Q · filed 2025-11-13 | -$1.67M derived: sum of 2 quarters · filed 2025-11-13 | -$2.00M derived: sum of 3 quarters · filed 2025-11-13 | -$2.38M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2023-12-31 | -$971.68K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.30M derived: sum of 2 quarters · filed 2025-03-31 | -$1.68M derived: sum of 3 quarters · filed 2025-03-31 | -$2.11M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$324.74K 10-Q · filed 2024-11-14 | -$704.18K derived: sum of 2 quarters · filed 2024-11-14 | -$1.14M 10-Q · filed 2024-11-14 | -$1.86M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$379.45K 10-Q · filed 2024-11-14 | -$813.52K 10-Q · filed 2024-08-14 | -$1.54M derived: sum of 3 quarters · filed 2024-11-14 | -$1.78M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-03-31 | -$434.07K 10-Q · filed 2024-11-14 | -$1.16M derived: sum of 2 quarters · filed 2024-11-14 | -$1.40M derived: sum of 3 quarters · filed 2024-11-14 | -$1.80M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2022-12-31 | -$723.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$963.29K derived: sum of 2 quarters · filed 2024-04-01 | -$1.37M derived: sum of 3 quarters · filed 2024-04-01 | -$1.67M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | -$240.22K 10-Q · filed 2023-11-14 | -$644.56K derived: sum of 2 quarters · filed 2023-11-14 | -$943.01K 10-Q · filed 2023-11-14 | -$1.92M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$404.34K 10-Q · filed 2023-11-14 | -$702.79K 10-Q · filed 2023-08-14 | -$1.68M derived: sum of 3 quarters · filed 2023-11-14 | -$2.25M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-03-31 | -$298.45K 10-Q · filed 2023-11-14 | -$1.28M derived: sum of 2 quarters · filed 2023-11-14 | -$1.85M derived: sum of 3 quarters · filed 2023-11-14 | -$2.49M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2021-12-31 | -$977.54K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$1.55M derived: sum of 2 quarters · filed 2023-03-31 | -$2.19M derived: sum of 3 quarters · filed 2023-03-31 | -$2.52M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | -$571.26K 10-Q · filed 2022-11-14 | -$1.21M derived: sum of 2 quarters · filed 2022-11-14 | -$1.55M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$642.23K 10-Q · filed 2022-08-11 | -$975.88K 10-Q · filed 2022-08-11 | ||||
| 2021-03-31 | -$333.65K 10-Q · filed 2022-05-13 | |||||
| 2020-12-31 | $354.77K 10-K/A · filed 2022-07-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |